EV/EBITDA
-1.41
-0.01-0.71%
Sat, 22 Feb 2025 00:58:43 GMT
Summary
- As of February 23, 2025, RGLS EV/EBITDA is -1.41, with a fall of -0.01 (-0.71%) during the most recent trading day.
- Over the past year, RGLS EV/EBITDA has dropped by -1.12 (-386.21%).
- RGLS EV/EBITDA is now -254.95% below its all-time high of 0.91.
Performance
RGLS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RGLS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.7% | +1.1% | +0.8% |
| 1 m1 month | +1.4% | -1.1% | -0.8% |
| 3 m3 months | +10.2% | -10.2% | -7.3% |
| 6 m6 months | +47.0% | -37.1% | -22.8% |
| ytdytd | +25.4% | -25.3% | -19.0% |
| 1 y1 year | -386.2% | +594.0% | -12.9% |
| 5 y5 years | -1040.0% | +2670.2% | -84.4% |
RGLS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -53.3% | -1.57 | +10.2% | |
| 3 m | 3-month | -0.92 | -53.3% | -2.16 | +34.7% |
| 6 m | 6-month | -0.92 | -53.3% | -3.02 | +53.3% |
| 1 y | 1-year | -0.23 | -513.0% | -5.86 | +75.9% |
| 3 y | 3-year | 0.87 | -262.1% | -5.86 | +75.9% |
| 5 y | 5-year | 0.91 | -254.9% | -8.60 | +83.6% |
| alltime | all time | 0.91 | -254.9% | -30.72 | +95.4% |
Regulus Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.41(-25.4%) |
| 2024 | -1.89(+1353.8%) |
| 2023 | -0.13(-31.6%) |
| 2022 | -0.19(-176.0%) |
| 2021 | 0.25(-105.2%) |
| 2020 | -4.80(-9700.0%) |
| 2019 | 0.05(-120.0%) |
| Date | Value |
|---|---|
| 2018 | -0.25(-85.4%) |
| 2017 | -1.71(+8.2%) |
| 2016 | -1.58(-80.7%) |
| 2015 | -8.19(-41.4%) |
| 2014 | -13.98(-20.0%) |
| 2013 | -17.48(+44.6%) |
| 2012 | -12.09 |
FAQ
- What is Regulus Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Regulus Therapeutics?
- What is RGLS EV/EBITDA year-to-date change?
- What is Regulus Therapeutics EV/EBITDA year-on-year change?
What is Regulus Therapeutics EV/EBITDA?
The current EV/EBITDA of RGLS is -1.41
What is the all time high EV/EBITDA for Regulus Therapeutics?
Regulus Therapeutics all-time high EV/EBITDA is 0.91
What is RGLS EV/EBITDA year-to-date change?
Regulus Therapeutics EV/EBITDA has changed by +0.48 (+25.40%) since the beginning of the year
What is Regulus Therapeutics EV/EBITDA year-on-year change?
Over the past year, RGLS EV/EBITDA has changed by -1.12 (-386.21%)